Cumulative Sales of BYO Probiotics Lineup Reaches 250 Billion Won
BYO Skin Probiotics, one of BYO Probiotics’ central products, alone has reached 200 million units in cumulative sales volume, with its cumulative sales amount recording 100 billion won ($72.2 mil).
CJ Wellcare entered the probiotics market in 2013 when it launched its exclusive BYO Skin Probiotics, developed by the CJ Probiotics R&D Center. BYO Skin Probiotics is Korea’s No. 1 skin immune probiotics product and has been certified by the Ministry of Food and Drug Safety, making it the first certification of this kind for a strain produced in Korea.
After launching BYO Probiotics in August 2015 to offer family consumers a product that helps boost both skin and intestines health, CJ Wellcare has further expanded their portfolio earlier this year — this time to explore diet probiotics. The company plans to focus on producing strains with new uses and characteristics, taking advantage of its unique capabilities in the field of probiotic research and development.
The reason behind the popularity of BYO Probiotics is their vitality and strength, which allows them to stay alive as they reach the intestines. Since plant-based probiotics CJLP were found at an acidity (pH) similar to that of stomach acid, it can create a healthy intestinal environment without being neutralized by stomach acid. This was enabled by a special four-type coating technology, developed by the CJ Probiotics R&D Center, that boosts the vitality of CJLP lactobacillus by forming a protective film on lactic acid bacteria. The company has received 34 patents globally, based on its unique technology alone.
CJ Wellcare is a healthcare company that became independent from CJ CheilJedang’s Health Business Department in January of this year. As the market leader in the area of premium probiotics of plant origin, CJ Wellcare intends to position itself as the forerunner in functional supplements for truly personalized health. In the mid- to long-term, this will be achieved through the expansion of its specialized product line that helps consumers with specific health problems. This plan is one part of a broader strategy from the company to strengthen and grow its Wellness business – Wellness being one of CJ’s four major growth engines – C.P.W.S. (Culture, Platform, Wellness and Sustainability) – and achieve 500 billion won in sales revenue by 2025.
